Showing 34,862 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Finance & funding

Second-line treatment nearly nine times more expensive than first-line in upper-middle income countries

News
9 August 2022

AIDS 2022: Could long-acting injectable cabotegravir and rilpivirine be self-administered? Tuesday 9 August 2022

August 2022
History of HIV & AIDS

‘Captain Condom’ Turned the Tide in Thailand’s War on AIDS and Overpopulation

Editor's pick
The New York Times
8 August 2022
Improving HIV care

Could Drones Provide HIV Care in Hard-to-Reach Areas?

Editor's pick
POZ
8 August 2022
Conference announcements & declarations

Do not let HIV and AIDS slide down the priority list

Editor's pick
The Economist (leader; free registration required)
8 August 2022
Human rights

‘Erasing our existence’: Ghana’s anti-LGBTQ+ bill blamed for rise in attacks

Editor's pick
The Guardian
8 August 2022
HIV & criminal law

Rugby star Gareth Thomas sued by ex claiming he "deceptively transmitted HIV"

Editor's pick
Gay Community News
8 August 2022
Global health initiatives

aidsmapLIVE: AIDS 2022 special Video

August 2022
Harm reduction

Pilot harm reduction programmes in Africa show progress, despite challenging laws and policies

News
8 August 2022
Improving HIV care

Virtually no screening and treatment for mental health disorders in many HIV clinics across the world

News
8 August 2022
Improving HIV care

In Africa, ‘the heart of HIV stigma’ is within healthcare settings

News
8 August 2022
Conception

UK government challenged over ‘cruel’ ban on people living with HIV using fertility treatment

Editor's pick
National AIDS Trust
8 August 2022
Low CD4 count

What will it take to end advanced HIV disease-related deaths?

News
8 August 2022
Treatment outcomes & life expectancy

Biktarvy Shows Durable Viral Suppression After 5 Years

Editor's pick
Infectious Disease Special Edition
5 August 2022
Migrants, refugees & displaced people

Australia: Why Access to Free HIV Treatment Is Important for Me

Editor's pick
Ending HIV
5 August 2022
People who inject drugs

Another record year for England and Wales drug deaths

Editor's pick
Drink and Drugs News
5 August 2022
Pharmaceutical industry

Gilead, despite R&D setbacks, sees commercial momentum in oncology

Editor's pick
FiercePharma
5 August 2022
Improving HIV care

Program Improves Care for Transgender People in Thailand

Editor's pick
Infectious Disease Special Edition
5 August 2022
Weight gain & lipodystrophy

Switching From Integrase Inhibitor to PI Trims Weight in HIV Patient Database

Editor's pick
NATAP
5 August 2022
Treatment simplification strategies

Macrophage Activation for 2 Years After Switch From 3 to 2 Antiretrovirals

Editor's pick
NATAP
5 August 2022
Hepatitis C treatment

Low CD4 Count Linked to DAA Failure in People With HIV

Editor's pick
NATAP
5 August 2022
Conference announcements & declarations

Four takeaways from the AIDS 2022 Conference

Editor's pick
Clinton Health Access Initiative
5 August 2022
Mpox (monkeypox)

Monkeypox vaccines: A virologist answers 6 questions about how they work, who can get them and how well they prevent infection

Editor's pick
The Conversation
5 August 2022
Ethnic & cultural minorities

New Zealand’s plan to eliminate HIV transmission ignores deepening inequities in health outcomes for Māori women

Editor's pick
The Conversation
5 August 2022